XtalPi (2228.HK), is a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaking medicine and innovative materials. XtalPi’s R&D platform integrates quantum physics and AI predictions with large-scale automated chemistry experiments to generate, screen, and validate novel compounds with tailored physiochemical properties and molecular functionalities. XtalPi leverages digitized and automated systems to optimize chemical synthesis, solid-state research, and chemistry data collection at scale. XtalPi uses AI, quantum physics, and automation to speed up drug discovery and materials research. They provide integrated solutions to streamline R&D processes, reducing time and waste in developing new therapies.